BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8855891)

  • 1. Methylenetetrahydrofolate reductase mutation and neural tube defects.
    Kirke PN; Mills JL; Whitehead AS; Molloy A; Scott JM
    Lancet; 1996 Oct; 348(9033):1037-8. PubMed ID: 8855891
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic Predisposition to Neural Tube Defects?
    Gibson KM; Bottiglieri T
    Pediatr Res; 2000 Aug; 48(2):135. PubMed ID: 10926283
    [No Abstract]   [Full Text] [Related]  

  • 3. MTHFR 677C-->T mutation, folate intake, neural-tube defect, and risk of cardiovascular disease.
    Wilcken DE
    Lancet; 1997 Aug; 350(9078):603-4. PubMed ID: 9288038
    [No Abstract]   [Full Text] [Related]  

  • 4. MTHFR 677C-->T mutation and neural-tube defects.
    Rizzari C; Valsecchi MG; Conter V
    Lancet; 1997 Nov; 350(9089):1479-80. PubMed ID: 9371193
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of the 677C-->T mutation on the methylenetetrahydrofolate reductase gene in Turkish patients with neural tube defects.
    Boduroğlu K; Alikaşifoğlu M; Anar B; Tunçbilek E
    J Child Neurol; 1999 Mar; 14(3):159-61. PubMed ID: 10190266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygote advantage of the MTHFR gene in patients with neural-tube defect and their relatives.
    Weitkamp LR; Tackels DC; Hunter AG; Holmes LB; Schwartz CE
    Lancet; 1998 May; 351(9115):1554-5. PubMed ID: 10326541
    [No Abstract]   [Full Text] [Related]  

  • 7. Relevance to spina bifida of mutated methylenetetrahydrofolate reductase.
    Wilcken DE; Wang XL
    Lancet; 1996 Feb; 347(8997):340. PubMed ID: 8569408
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevalence of methylenetetrahydrofolate reductase (MTHFR) gene polymorphism (C677T) in the Hungarian population].
    Czeizel E; Tímár L; Botto L
    Orv Hetil; 2001 Jun; 142(23):1227-9. PubMed ID: 11433922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 677-->CT mutation on the methylenetetrahydrofolate reductase gene is not a risk factor for neural tube defects in Turkey.
    Boduroglu K; Alikasifoglu M; Anar B; Tuncbilek E
    Arch Dis Child Fetal Neonatal Ed; 1998 May; 78(3):F235. PubMed ID: 9713045
    [No Abstract]   [Full Text] [Related]  

  • 10. The thermolabile variant of methylenetetrahydrofolate reductase (MTHFR) is not a major risk factor for neural tube defect in American Caucasians. The NTD Collaborative Group.
    Speer MC; Worley G; Mackey JF; Melvin E; Oakes WJ; George TM
    Neurogenetics; 1997 Sep; 1(2):149-50. PubMed ID: 10732818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human T and risk for neural tube defects.
    Richter B; Schultealbert AH; Koch MC
    J Med Genet; 2002 Mar; 39(3):E14. PubMed ID: 11897834
    [No Abstract]   [Full Text] [Related]  

  • 12. High prevalence of the thermolabile methylenetetrahydrofolate reductase variant in Mexico: a country with a very high prevalence of neural tube defects.
    Mutchinick OM; López MA; Luna L; Waxman J; Babinsky VE
    Mol Genet Metab; 1999 Dec; 68(4):461-7. PubMed ID: 10607475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 677 C-->T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in five Chinese ethnic groups.
    Yu J; Chen B; Zhang G; Fu S; Li P
    Hum Hered; 2000; 50(4):268-70. PubMed ID: 10782023
    [No Abstract]   [Full Text] [Related]  

  • 14. Decreased proportion of female newborn infants homozygous for the 677 C-->T mutation in methylenetetrahydrofolate reductase.
    Rozen R; Fraser FC; Shaw G
    Am J Med Genet; 1999 Mar; 83(2):142-3. PubMed ID: 10190487
    [No Abstract]   [Full Text] [Related]  

  • 15. Possible interaction of genotypes at cystathionine beta-synthase and methylenetetrahydrofolate reductase (MTHFR) in neural tube defects. NTD Collaborative Group.
    Speer MC; Nye J; McLone D; Worley G; Melvin EC; Viles KD; Franklin A; Drake C; Mackey J; George TM
    Clin Genet; 1999 Aug; 56(2):142-4. PubMed ID: 10517251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural tube defects, methylenetetrahydrofolate reductase mutation, and north/south dietary differences in China.
    Melnick M; Marazita ML
    J Craniofac Genet Dev Biol; 1998; 18(4):233-5. PubMed ID: 10100053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects.
    Ou CY; Stevenson RE; Brown VK; Schwartz CE; Allen WP; Khoury MJ; Rozen R; Oakley GP; Adams MJ
    Am J Med Genet; 1996 Jun; 63(4):610-4. PubMed ID: 8826441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in frequencies of heterozygous thermolabile 5,10-methylenetetrahydrofolate reductase gene in fetuses with neural tube defects.
    Johanning GL; Wenstrom KD; Tamura T
    J Med Genet; 2002 May; 39(5):366-7. PubMed ID: 12011159
    [No Abstract]   [Full Text] [Related]  

  • 19. Abnormal folate metabolism and neural tube defects.
    Davis RE
    Med J Aust; 1996 Apr; 164(8):509-10. PubMed ID: 8614353
    [No Abstract]   [Full Text] [Related]  

  • 20. Differences in methylenetetrahydrofolate reductase genotype frequencies, between Whites and Blacks.
    Stevenson RE; Schwartz CE; Du YZ; Adams MJ
    Am J Hum Genet; 1997 Jan; 60(1):229-30. PubMed ID: 8981967
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.